Control of enteric neuromuscular functions by purinergic A 3 receptors in normal rat distal colon and experimental bowel inflammation

British Journal of Pharmacology

Volumn 161, Issue 4, 2010, Pages 856-871

  Antonioli, L ^a   Fornai, M ^a   Colucci, R ^a   Ghisu, N ^a   Tuccori, M ^a   Awwad, O ^a   Bin, A ^b   Zoppellaro, C ^b   Castagliuolo, I ^b   Gaion, R M ^b   Giron, M C ^b   Blandizzi, C ^a  

^a UNIVERSITY OF PISA   (Italy)

^b UNIVERSITY OF PADOVA   (Italy)

Author keywords

A 3 receptor; adenosine; colonic neuromuscular contractions; DNBS colitis; rat

Indexed keywords

2 CHLORO N6 (3 IODOBENZYL)ADENOSINE 5' N METHYLURONAMIDE; 6 ETHYL 2 PHENYL 4 PROPYL 3 PYRIDINECARBOXYLIC ACID 5 THIOCARBOXYLIC ACID 5 ETHYL 3 PROPYL ESTER; ADENOSINE A3 RECEPTOR; ADENOSINE A3 RECEPTOR AGONIST; ADENOSINE DEAMINASE; CARBACHOL; DIPYRIDAMOLE; MESSENGER RNA; NITROBENZENE DERIVATIVE; PURINERGIC RECEPTOR; SULFONIC ACID DERIVATIVE; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CHOLINERGIC SYSTEM; COLITIS; COLON MOTILITY; CONCENTRATION RESPONSE; CONTROLLED STUDY; ELECTROSTIMULATION; ENZYME ASSAY; IMMUNOFLUORESCENCE; INTESTINE INNERVATION; MALE; MUSCLE CONTRACTION; MYENTERIC PLEXUS; NEUROMUSCULAR FUNCTION; NONHUMAN; PRIORITY JOURNAL; RAT; REGULATORY MECHANISM; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

ADENOSINE; ADENOSINE DEAMINASE; ANIMALS; BENZENESULFONATES; CARBACHOL; COLITIS; COLON; DISEASE MODELS, ANIMAL; ELECTRIC STIMULATION; FLUORESCENT ANTIBODY TECHNIQUE; MALE; MYENTERIC PLEXUS; RATS; RATS, SPRAGUE-DAWLEY; RECEPTOR, ADENOSINE A3; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 77957223893     PISSN: 00071188     EISSN: 14765381     Source Type: Journal    
DOI: 10.1111/j.1476-5381.2010.00917.x     Document Type: Article

References (49)

1. Alexander SP, Mathie A, Peters JA (2009). Guide to Receptors and Channels (GRAC), 4th edition. Br J Pharmacol 158 : S1 S254. (Pubitemid 351415518)
2. Antonioli L, Fornai M, Colucci R, Ghisu N, Blandizzi C, Del Tacca M (2006). A2a receptors mediate inhibitory effects of adenosine on colonic motility in the presence of experimental colitis. Inflamm Bowel Dis 12 : 117 122.
3. Antonioli L, Fornai M, Colucci R, Ghisu N, Da Settimo F, Natale G et al. (2007). Inhibition of adenosine deaminase attenuates inflammation in experimental colitis. J Pharmacol Exp Ther 322 : 435 442. (Pubitemid 47105786)
4. Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M et al. (2008a). Pharmacological modulation of adenosine system: novel options for treatment of inflammatory bowel diseases. Inflamm Bowel Dis 14 : 566 574. (Pubitemid 351571838)
5. Antonioli L, Fornai M, Colucci R, Ghisu N, Tuccori M, Del Tacca M et al. (2008b). Regulation of enteric functions by adenosine: pathophysiological and pharmacological implications. Pharmacol Ther 120 : 233 253.
6. Bar-Yehuda S, Silverman MH, Kerns WD, Ochaion A, Cohen S, Fishman P (2007). The anti-inflammatory effect of A3 adenosine receptor agonists: a novel targeted therapy for rheumatoid arthritis. Expert Opin Investig Drugs 16 : 1601 1613. (Pubitemid 350028410)
7. Blandizzi C, Fornai M, Colucci R, Baschiera F, Barbara G, De Giorgio R et al. (2003). Altered prejunctional modulation of intestinal cholinergic and noradrenergic pathways by alpha 2-adrenoceptors in the presence of experimental colitis. Br J Pharmacol 139 : 309 320. (Pubitemid 36760363)
8. 3 receptors inhibits the enteric short inter-plexus neural circuit triggered by histamine. Am J Physiol Gastrointest Liver Physiol 297 : G1147 G1162.
9. Bozkurt TE, Sahin-Erdemli I (2008). Rat urinary bladder-derived relaxant factor: studies on its nature and release by coaxial bioassay system. Eur J Pharmacol 591 : 273 279.
10. Burnstock G (2006). Pathophysiology and therapeutic potential of purinergic signaling. Pharmacol Rev 58 : 58 86. (Pubitemid 43313697)
11. Burnstock G (2008). Purinergic receptors as future targets for treatment of functional GI disorders. Gut 57 : 1193 1194.
12. Christofi FL (2008). Purinergic receptors and gastrointestinal secretomotor function. Purinergic Signal 4 : 213 236.
13. Christofi FL, Wood JD (1993). Presynaptic inhibition by adenosine A1 receptors on guinea pig small intestinal myenteric neurons. Gastroenterology 104 : 1420 1429.
14. Christofi FL, McDonald TJ, Cook MA (1990). Adenosine receptors are coupled negatively to release of tachykinin(s) from enteric nerve endings. J Pharmacol Exp Ther 253 : 290 295.
15. Correia-de-Sá P, Adães S, Timóteo MA, Vieira C, Magalhães-Cardoso T, Nascimento C et al. (2006). Fine-tuning modulation of myenteric motoneurons by endogenous adenosine: on the role of secreted adenosine deaminase. Auton Neurosci 126-127 : 211 224. (Pubitemid 43816917)
16. De Man JG, Moreels TG, De Winter BY, Bogers JJ, Van Marck EA, Herman AG et al. (2001). Disturbance of the prejunctional modulation of cholinergic neurotransmission during chronic granulomatous inflammation of the mouse ileum. Br J Pharmacol 133 : 695 707.
17. Depoortere I, Thijs T, Janssen S, De Smet B, Tack J (2010). Colitis affects the smooth muscle and neural response to motilin in the rabbit antrum. Br J Pharmacol 159 : 384 393.
18. De Schepper HU, De Man JG, Moreels TG, Pelckmans PA, De Winter BY (2008). Review article: gastrointestinal sensory and motor disturbances in inflammatory bowel disease - clinical relevance and pathophysiological mechanisms. Aliment Pharmacol Ther 27 : 621 637.
19. Drew GM, Mitchell VA, Vaughan CW (2005). Postsynaptic actions of substance P on rat periaqueductal grey neurons in vitro. Neuropharmacology 49 : 587 595.
20. Duarte-Araùjo M, Nascimento C, Timoteo MA, Magalhães-Cardoso T, Correia-de-Sá P (2004). Dual effects of adenosine on acetylcholine release from myenteric motoneurons are mediated by junctional facilitatory A2a and extrajunctional inhibitory A1 receptors. Br J Pharmacol 141 : 925 934. (Pubitemid 38510075)
21. Eltzschig HK, Faigle M, Knapp S, Karhausen J, Ibla J, Rosenberger P et al. (2006). Endothelial catabolism of extracellular adenosine during hypoxia: the role of surface adenosine deaminase and CD26. Blood 108 : 1602 1610. (Pubitemid 44316128)
22. Fishman P, Bar-Yehuda S, Madi L, Rath-Wolfson L, Ochaion A, Cohen S et al. (2006). The PI3K-NF-kappaB signal transduction pathway is involved in mediating the anti-inflammatory effect of IB-MECA in adjuvant-induced arthritis. Arthritis Res Ther 8 : R33.
23. Fornai M, Blandizzi C, Antonioli L, Colucci R, Bernardini N, Segnani C et al. (2006). Differential role of cyclooxygenase 1 and 2 isoforms in the modulation of colonic neuromuscular function in experimental inflammation. J Pharmacol Exp Ther 317 : 938 945. (Pubitemid 43764095)
24. Fornai M, Antonioli L, Colucci R, Ghisu N, Buccianti P, Marioni A et al. (2009). A1 and A2a receptors mediate inhibitory effects of adenosine on the motor activity of human colon. Neurogastroenterol Motil 21 : 451 466.
25. Fozard JR, Baur F, Wolber C (2003). Antagonist pharmacology of adenosine A2B receptors from rat, guinea pig and dog. Eur J Pharmacol 475 : 79 84. (Pubitemid 37088009)
26. Fredholm BB, IJzerman AP, Jacobson KA, Klotz KN, Linden J (2001). International Union of Pharmacology. XXV. Nomenclature and classification of adenosine receptors. Pharmacol Rev 53 : 527 552. (Pubitemid 33136237)
27. Gessi S, Merighi S, Varani K, Leung E, Mac Lennan S, Borea PA (2008). The A3 adenosine receptor: an enigmatic player in cell biology. Pharmacol Ther 117 : 123 140. (Pubitemid 350192673)
28. Giron MC, Bin A, Brun P, Etteri S, Bolego C, Florio C et al. (2008). Cyclic AMP in rat ileum: evidence for the presence of an extracellular cyclic AMP-adenosine pathway. Gastroenterology 134 : 1116 1126. (Pubitemid 351451977)
29. Guzman J, Yu JG, Suntres Z, Bozarov A, Cooke H, Javed N et al. (2006). ADOA3R as a therapeutic target in experimental colitis: proof by validated high-density oligonucleotide microarray analysis. Inflamm Bowel Dis 12 : 766 789. (Pubitemid 44253762)
30. Haskó G, Linden J, Cronstein B, Pacher P (2008). Adenosine receptors: therapeutic aspects for inflammatory and immune diseases. Nat Rev Drug Discov 7 : 759 770.
31. Ianowski JP, Choi JY, Wine JJ, Hanrahan JW (2008). Substance P stimulates CFTR-dependent fluid secretion by mouse tracheal submucosal glands. Pflugers Arch 457 : 529 537.
32. Jackson EK, Zhu C, Tofovic SP (2002). Expression of adenosine receptors in the preglomerular microcirculation. Am J Physiol Renal Physiol 283 : F41 F51. (Pubitemid 34680470)
33. Liu C, Liu JK, Kan MJ, Gao L, Fu HY, Zhou H et al. (2007). Morphine enhances purine nucleotide catabolism in vivo and in vitro. Acta Pharmacol Sin 28 : 1105 1115. (Pubitemid 47197770)
34. Mabley J, Soriano F, Pacher P, Haskó G, Marton A, Wallace R et al. (2003). The adenosine A3 receptor agonist, N6-(3-iodobenzyl)-adenosine- 5′-N-methyluronamide, is protective in two murine models of colitis. Eur J Pharmacol 466 : 323 329. (Pubitemid 36412095)
35. Madi L, Cohen S, Ochayin A, Bar-Yehuda S, Barer F, Fishman P (2007). Overexpression of A3 adenosine receptor in peripheral blood mononuclear cells in rheumatoid arthritis: involvement of nuclear factor-kappaB in mediating receptor level. J Rheumatol 34 : 20 26. (Pubitemid 46106558)
36. Mazzone A, Farrugia G (2007). Evolving concepts in the cellular control of gastrointestinal motility: neurogastroenterology and enteric sciences. Gastroenterol Clin North Am 36 : 499 513. (Pubitemid 47575838)
37. Neunlist M, Aubert P, Toquet C, Oreshkova T, Barouk J, Lehur PA et al. (2003). Changes in chemical coding of myenteric neurones in ulcerative colitis. Gut 52 : 84 90. (Pubitemid 36020771)
38. Ochaion A, Bar-Yehuda S, Cohen S, Amital H, Jacobson KA, Joshi BV et al. (2008). The A3 adenosine receptor agonist CF502 inhibits the PI3K, PKB/Akt and NF-kappaB signaling pathway in synoviocytes from rheumatoid arthritis patients and in adjuvant induced arthritis rats. Biochem Pharmacol 76 : 482 494.
39. Ochaion A, Bar-Yehuda S, Cohen S, Barer F, Patoka R, Amital H et al. (2009). The anti-inflammatory target A(3) adenosine receptor is over-expressed in rheumatoid arthritis, psoriasis and Crohn's disease. Cell Immunol 258 : 115 122.
40. Schwiebert EM, Fitz JG (2008). Purinergic signaling microenvironments: an introduction. Purinergic Signal 4 : 89 92.
41. Silverman MH, Strand V, Markovits D, Nahir M, Reitblat T, Molad Y et al. (2008). Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial. J Rheumatol 35 : 41 48.
42. Suthamnatpong N, Hata F, Kanada A, Takeuchi T, Yagasaki O (1993). Mediators of nonadrenergic, noncholinergic inhibition in the proximal, middle and distal regions of rat colon. Br J Pharmacol 108 : 348 355. (Pubitemid 23032538)
43. Timóteo MA, Oliveira L, Campesatto-Mella E, Barroso A, Silva C, Magalhães Cardoso MT et al. (2008). Tuning adenosine A1 and A2A receptors activation mediates L-citrulline-induced inhibition of [3H] acetylcholine release depending on nerve stimulation pattern. Neurochem Int 52 : 834 845.
44. Van der Hoeven D, Wan TC, Auchampach JA (2008). Activation of the A(3) adenosine receptor suppresses superoxide production and chemotaxis of mouse bone marrow neutrophils. Mol Pharmacol 74 : 685 696.
45. Volonté C, D'Ambrosi N, Amadio S (2008). Protein cooperation: from neurons to networks. Prog Neurobiol 86 : 61 71.
46. Wells RW, Blennerhassett MG (2004). Persistent and selective effects of inflammation on smooth muscle cell contractility in rat colitis. Pflugers Arch 448 : 515 524.
47. Wolber C, Fozard JR (2005). The receptor mechanism mediating the contractile response to adenosine on lung parenchymal strips from actively sensitized, allergen-challenged Brown Norway rats. Naunyn Schmiedebergs Arch Pharmacol 371 : 158 168. (Pubitemid 40487421)
48. Wunderlich JE, Needleman BJ, Chen Z, Yu JG, Wang Y, Grants I et al. (2008). Dual purinergic synaptic transmission in the human enteric nervous system. Am J Physiol Gastrointest Liver Physiol 294 : G554 G566. (Pubitemid 351253340)
49. Zizzo MG, Bonomo A, Belluardo N, Mulè F, Serio R (2009). A1 receptors mediate adenosine inhibitory effects in mouse ileum via activation of potassium channels. Life Sci 84 : 772 778.